Foresite Capital Management IV, LLC MAZE — Maze Therapeutics Inc

Ownership history in Foresite Capital Management IV, LLC  ·  5 quarters on record

AI Ownership Summary

Foresite Capital Management IV, LLC reported Maze Therapeutics Inc (MAZE) in 5 quarterly 13F filings from 2025 Q1 through 2026 Q1. Peak portfolio weight reached 20.93% in 2025 Q1. The latest visible filing shows MAZE at 1.98% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this MAZE ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Foresite Capital Management IV, LLC's position in Maze Therapeutics Inc, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

MAZE was reported at 1.98% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
20.93% in 2025 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q1 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

MAZE stock page Foresite Capital Management IV, LLC fund profile Foresite Capital Management IV, LLC full holdings
How Foresite Capital Management IV, LLC held MAZE — position size vs. price
% of Fund (quarterly)    MAZE price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 5 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED — — — 156,901 -365,756 -70.0% 1.98% $4.7M 2026-05-15 $25.56
2025 Q4 UNCHANGED — — — 522,657 — 0% 9.43% $21.7M 2026-02-17 $46.97
2025 Q3 REDUCED 75.3% +56.4% ❌ 522,657 -1,589,262 -75.3% 7.42% $13.6M 2025-11-14 $32.53
2025 Q2 UNCHANGED — — — 2,111,919 — 0% 20.93% $25.9M 2025-08-12 $13.74
2025 Q1 INITIATED — — — 2,111,919 — — 20.93% $23.3M 2025-05-15 $9.25

🏢 Other funds also holding MAZE

As of 2026 Q1 — sorted by position size

TRV GP IV, LLC 3Y 50.04% ARCH Venture Management, LLC 3Y 7Y 18.16% General Catalyst Group Management, LLC 3Y 7Y 16.85% TRV GP V, LLC 7.08% WASHINGTON UNIVERSITY 3Y 5.23% a16z Capital Management, L.L.C. 3.94% Frazier Life Sciences Management, L.P. 3Y 3.51% Squadron Capital Management LLC 2.82% Ally Bridge Group (NY) LLC 3Y 2.41% Logos Global Management LP 3Y 1.84%

FAQ About Foresite Capital Management IV, LLC and MAZE

These are the practical questions this page is built to answer before you even open the full history table.

How long has Foresite Capital Management IV, LLC reported owning MAZE?

Foresite Capital Management IV, LLC reported MAZE across 5 quarterly 13F filings, from 2025 Q1 through 2026 Q1.

What was the largest reported MAZE position in Foresite Capital Management IV, LLC's portfolio?

The largest reported portfolio weight for MAZE was 20.93% in 2025 Q1.

What is the latest reported MAZE position on this page?

The most recent filing on this page is 2026 Q1, when Foresite Capital Management IV, LLC reported 156,901 shares, equal to 1.98% of portfolio, with an estimated market value of $4.7M.

What does the chart on this MAZE ownership page compare?

The chart compares Foresite Capital Management IV, LLC's quarterly MAZE portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to Foresite Capital Management IV, LLC Holdings